{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T21:09:51Z","timestamp":1780088991124,"version":"3.54.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007647","name":"National Taiwan University College of Medicine","doi-asserted-by":"publisher","award":["NTUCCS-112-23"],"award-info":[{"award-number":["NTUCCS-112-23"]}],"id":[{"id":"10.13039\/501100007647","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010425","name":"Tri-Service General Hospital","doi-asserted-by":"publisher","award":["TSGH-A-115011"],"award-info":[{"award-number":["TSGH-A-115011"]}],"id":[{"id":"10.13039\/501100010425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006477","name":"National Taiwan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006477","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019000","name":"Ministry of National Defense Medical Affairs Bureau","doi-asserted-by":"publisher","award":["MND-MAB-D-115124"],"award-info":[{"award-number":["MND-MAB-D-115124"]}],"id":[{"id":"10.13039\/501100019000","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Medical Informatics"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ijmedinf.2026.106402","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T09:36:54Z","timestamp":1773826614000},"page":"106402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A visualized nurse-led ePRO system for chemotherapy toxicity: Content design and validation"],"prefix":"10.1016","volume":"214","author":[{"given":"Chiao-Chi","family":"Kuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jhe-Cyuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2865-6760","authenticated-orcid":false,"given":"Shan-Hsiang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiun","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Ming","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Kang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9020-3279","authenticated-orcid":false,"given":"Hsueh-Hsing","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ijmedinf.2026.106402_b0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"5","key":"10.1016\/j.ijmedinf.2026.106402_b0010","first-page":"261","article-title":"Evolution of chemotherapy","volume":"41","author":"Kennedy","year":"1991","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.ijmedinf.2026.106402_b0015","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.gendis.2022.02.007","article-title":"Cancer chemotherapy and beyond: current status, drug candidates, associated risks and progress in targeted therapeutics","volume":"10","author":"Anand","year":"2023","journal-title":"Genes Dis."},{"issue":"3","key":"10.1016\/j.ijmedinf.2026.106402_b0020","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.critrevonc.2013.12.006","article-title":"Risk factors for febrile neutropenia among patients with cancer receiving chemotherapy: a systematic review","volume":"90","author":"Lyman","year":"2014","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"12","key":"10.1016\/j.ijmedinf.2026.106402_b0025","first-page":"628","article-title":"A prospective, real-world, multinational study of febrile neutropenia (FN) occurrence in oncology patients receiving chemotherapy with intermediate risk of FN: a MASCC neutropenia, infection, and myelosuppression study group initiative","volume":"31","author":"Rapoport","year":"2023","journal-title":"Support Care Cancer"},{"issue":"11","key":"10.1016\/j.ijmedinf.2026.106402_b0030","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41571-022-00685-3","article-title":"Mitigating acute chemotherapy-associated adverse events in patients with cancer","volume":"19","author":"Kuderer","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.ijmedinf.2026.106402_b0035","doi-asserted-by":"crossref","DOI":"10.2196\/14418","article-title":"A web-based exercise system (e-CuidateChemo) to counter the side effects of chemotherapy in patients with breast cancer: randomized controlled trial","volume":"21","author":"Ariza-Garcia","year":"2019","journal-title":"J. Med. Internet Res."},{"issue":"24","key":"10.1016\/j.ijmedinf.2026.106402_b0040","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1001\/jama.2022.9265","article-title":"Effect of electronic symptom monitoring on patient-reported outcomes among patients with metastatic cancer: a randomized clinical trial","volume":"327","author":"Basch","year":"2022","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ijmedinf.2026.106402_b0045","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1188\/16.CJON.589-591","article-title":"Managing chemotherapy side effects: achieving reliable and equitable outcomes","volume":"20","author":"Beaver","year":"2016","journal-title":"Clin. J. Oncol. Nurs."},{"issue":"6","key":"10.1016\/j.ijmedinf.2026.106402_b0050","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1200\/JCO.2015.63.0830","article-title":"Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial","volume":"34","author":"Basch","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ijmedinf.2026.106402_b0055","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1023\/A:1010684903199","article-title":"Tolerability of hormone therapies for breast cancer: how informative are documented symptom profiles in medical notes for 'well-tolerated' treatments","volume":"66","author":"Fellowes","year":"2001","journal-title":"Breast Cancer Res. Treat."},{"issue":"12","key":"10.1016\/j.ijmedinf.2026.106402_b0060","doi-asserted-by":"crossref","first-page":"e1943","DOI":"10.1200\/OP.22.00360","article-title":"Adaptation of remote symptom monitoring using electronic patient-reported outcomes for implementation in real-world settings","volume":"18","author":"Rocque","year":"2022","journal-title":"JCO Oncol. Pract."},{"issue":"15_suppl","key":"10.1016\/j.ijmedinf.2026.106402_b0065","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2021.39.15_suppl.12000","article-title":"Randomized trial of remote cancer symptom monitoring during COVID-19: impact on symptoms, QoL, and unplanned health care utilization","volume":"39","author":"Mooney","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.ijmedinf.2026.106402_b0070","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1056\/NEJMp0911494","article-title":"The missing voice of patients in drug-safety reporting","volume":"362","author":"Basch","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.ijmedinf.2026.106402_b0075","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1001\/jamaoncol.2015.4719","article-title":"Missing patients' symptoms in cancer care delivery\u2014the importance of patient-reported outcomes","volume":"2","author":"Basch","year":"2016","journal-title":"JAMA Oncol."},{"issue":"3","key":"10.1016\/j.ijmedinf.2026.106402_b0080","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1001\/jamaoncol.2015.0530","article-title":"Patient-reported outcomes in cancer drug development and US regulatory review: perspectives from industry, the Food and Drug Administration, and the patient","volume":"1","author":"Basch","year":"2015","journal-title":"JAMA Oncol."},{"issue":"7","key":"10.1016\/j.ijmedinf.2026.106402_b0085","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1200\/JCO.20.02015","article-title":"Phase III randomized controlled trial of eRAPID: eHealth intervention during chemotherapy","volume":"39","author":"Absolom","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ijmedinf.2026.106402_b0090","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1200\/JCO.2013.48.6662","article-title":"Electronic self-report assessment for cancer and self-care support: results of a multicenter randomized trial","volume":"32","author":"Berry","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.ijmedinf.2026.106402_b0095","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1200\/JCO.21.01344","article-title":"Patient-reported outcome-based symptom management versus usual care after lung cancer surgery: a multicenter randomized controlled trial","volume":"40","author":"Dai","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ijmedinf.2026.106402_b0100","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1200\/JCO.2013.52.2219","article-title":"Adverse event reporting in cancer clinical trial publications","volume":"32","author":"Sivendran","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.ijmedinf.2026.106402_b0105","doi-asserted-by":"crossref","first-page":"116","DOI":"10.5662\/wjm.v11.i4.116","article-title":"Delphi methodology in healthcare research: how to decide its appropriateness","volume":"11","author":"Nasa","year":"2021","journal-title":"World J. Methodol."},{"issue":"9","key":"10.1016\/j.ijmedinf.2026.106402_b0110","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju244","article-title":"Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)","volume":"106","author":"Basch","year":"2014","journal-title":"J. Natl Cancer Inst."},{"issue":"15","key":"10.1016\/j.ijmedinf.2026.106402_b0115","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1200\/JCO.2005.04.275","article-title":"Patient online self-reporting of toxicity symptoms during chemotherapy","volume":"23","author":"Basch","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.ijmedinf.2026.106402_b0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241983","article-title":"Evaluating the content validity of two versions of an instrument used in measuring pediatric pain knowledge and attitudes in the Ghanaian context","volume":"15","author":"Kusi Amponsah","year":"2020","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ijmedinf.2026.106402_b0125","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jamadermatol.2023.5519","article-title":"Development and validation of a patient-reported outcome measure to assess disease control in chronic prurigo","volume":"160","author":"Metz","year":"2024","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.ijmedinf.2026.106402_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinepi.2025.111879","article-title":"Content validity: judging the relevance, comprehensiveness, and comprehensibility of an outcome measurement instrument \u2013 a COSMIN perspective","volume":"185","author":"Mokkink","year":"2025","journal-title":"J. Clin. Epidemiol."},{"issue":"3 Pt 1","key":"10.1016\/j.ijmedinf.2026.106402_b0135","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2466\/pms.105.3.997-1014","article-title":"An overview of coefficient alpha and a reliability matrix for estimating adequacy of internal consistency coefficients with psychological research measures","volume":"105","author":"Ponterotto","year":"2007","journal-title":"Percept. Mot. Skills"},{"issue":"7","key":"10.1016\/j.ijmedinf.2026.106402_b0140","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1007\/s11136-023-03374-5","article-title":"Reliability and validity of PRO-CTCAE\u00ae daily reporting with a 24-hour recall period","volume":"32","author":"Lee","year":"2023","journal-title":"Qual. Life Res."},{"issue":"8","key":"10.1016\/j.ijmedinf.2026.106402_b0145","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/jamaoncol.2015.2639","article-title":"Validity and reliability of the US National Cancer Institute\u2019s Patient-Reported Outcomes Version of the Common Terminology Criteria for adverse events (PRO-CTCAE)","volume":"1","author":"Dueck","year":"2015","journal-title":"JAMA Oncol."},{"issue":"5","key":"10.1016\/j.ijmedinf.2026.106402_b0150","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1046\/j.1365-2648.1997.1997025999.x","article-title":"Psychometric evaluation of a questionnaire to document side-effects of chemotherapy","volume":"25","author":"Sitzia","year":"1997","journal-title":"J. Adv. Nurs."},{"issue":"11","key":"10.1016\/j.ijmedinf.2026.106402_b0155","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1007\/s11136-020-02558-7","article-title":"Clinicians versus patients subjective adverse events assessment: based on patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)","volume":"29","author":"Liu","year":"2020","journal-title":"Qual. Life Res."},{"issue":"13","key":"10.1016\/j.ijmedinf.2026.106402_b0160","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1002\/cncr.32898","article-title":"Congruence of patient- and clinician-reported toxicity in women receiving chemotherapy for early breast cancer","volume":"126","author":"Nyrop","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.ijmedinf.2026.106402_b0165","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejca.2023.01.005","article-title":"Reliability of patient-reported toxicities during adjuvant chemotherapy","volume":"182","author":"Cremante","year":"2023","journal-title":"Eur. J. Cancer"},{"issue":"4","key":"10.1016\/j.ijmedinf.2026.106402_b0170","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/jamaoncol.2015.4720","article-title":"Self-evaluation of adjuvant chemotherapy-related adverse effects by patients with breast cancer","volume":"2","author":"Montemurro","year":"2016","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ijmedinf.2026.106402_b0175","article-title":"Real time remote symptom monitoring during chemotherapy for cancer: European multicenter randomised controlled trial (eSMART)","volume":"374","author":"Maguire","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ijmedinf.2026.106402_b0180","doi-asserted-by":"crossref","DOI":"10.2196\/53834","article-title":"Patients\u2019 and clinicians\u2019 experiences using a real-time remote monitoring system for chemotherapy symptom management (ASyMS): qualitative study","volume":"26","author":"McCann","year":"2024","journal-title":"J. Med. Internet Res."},{"issue":"10_suppl","key":"10.1016\/j.ijmedinf.2026.106402_b0185","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1200\/OP.2024.20.10_suppl.406","article-title":"Development and implementation of a digital remote symptom monitoring program (RESPONSe) to support patients undergoing IV chemotherapy at a community ambulatory cancer clinic in Richmond BC Canada","volume":"20","author":"Ho","year":"2024","journal-title":"JCO Oncol Pract."},{"issue":"9","key":"10.1016\/j.ijmedinf.2026.106402_b0190","article-title":"Essential components of an electronic patient-reported symptom monitoring and management system: a randomized clinical trial, JAMA Netw. Open","volume":"7","author":"Mooney","year":"2024"},{"issue":"8","key":"10.1016\/j.ijmedinf.2026.106402_b0195","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1158\/1078-0432.CCR-17-2555","article-title":"Use of PRO measures to inform tolerability in oncology trials: implications for clinical review IND safety reporting and clinical site inspections","volume":"24","author":"Kim","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.ijmedinf.2026.106402_b0200","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.clbc.2013.02.014","article-title":"The validity and utility of the MD Anderson Symptom Inventory in patients with breast cancer: evidence from the symptom outcomes and practice patterns data from the Eastern Cooperative Oncology Group","volume":"13","author":"Mendoza","year":"2013","journal-title":"Clin. Breast Cancer"},{"issue":"6","key":"10.1016\/j.ijmedinf.2026.106402_b0205","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s40271-022-00584-w","article-title":"Interpreting within-patient changes on the EORTC QLQ-C30 and EORTC QLQ-LC13","volume":"15","author":"Coon","year":"2022","journal-title":"Patient"},{"issue":"1","key":"10.1016\/j.ijmedinf.2026.106402_b0210","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.1038\/s41598-021-84681-0","article-title":"Temporal stability of quality of life assessments in patients with cancer","volume":"11","author":"Hinz","year":"2021","journal-title":"Sci. Rep."}],"container-title":["International Journal of Medical Informatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386505626001425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386505626001425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:37:15Z","timestamp":1780087035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386505626001425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":42,"alternative-id":["S1386505626001425"],"URL":"https:\/\/doi.org\/10.1016\/j.ijmedinf.2026.106402","relation":{},"ISSN":["1386-5056"],"issn-type":[{"value":"1386-5056","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A visualized nurse-led ePRO system for chemotherapy toxicity: Content design and validation","name":"articletitle","label":"Article Title"},{"value":"International Journal of Medical Informatics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijmedinf.2026.106402","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106402"}}